Shake It UpFind another product, model, brand or retailer
RPReal Peptides
Cagrilintide - 10mg
99% Pure | Multi Dose | Finished in the USA Cagrilintide is a powerful, long-acting analogue of the naturally secreted hormone amylin—co-released with insulin. Designed to probe appetite control , glycemic balance , and fat-metabolism in lab models, Cagrilintide slows gastric emptying, modulates satiety pathways, and drives body-fat reduction in rodent and primate studies.
When paired with GLP-1 agonists like semaglutide or retatrutide, it delivers amplified metabolic effects. Each 10 mg vial is HPLC-tested to ≥99% purity, endotoxin-screened (
Price integrityGood confidence · 80/100PriceShaker found no major pricing-integrity warning in the data currently available.
Shake Score 70.6/100
PS Verified Saving 11.1%
Retailer claimed saving 60.0%
Observed range $124.80 – $156.00
Current price position Near observed low
Latest movement Down $31.20 (20.0%)
PRICE MOVEMENTDown $31.20 (20.0%)Latest recorded movement: $156.00 to $124.80 between 9 Oct and 6 Nov.
SHOULD I BUY NOW?Building price historyPriceShaker is collecting independent observations before issuing a verified buy/wait verdict.
PriceShakerEMAIL PRICE ALERT
Tell PriceShaker how often to check. We only message you when the observed price actually moves up or down.
PRICESHAKER PRODUCT SNAPSHOT
Live price evidence for Cagrilintide - 10mg
PriceShaker compares eligible live retailer offers in your selected market and keeps retailer-supplied claims separate from prices we have independently observed over time.
Live comparison1 retailer from $124.80Lowest eligible current price shown first.
Product identifiersCatalogue matchedMatched from available product evidence.
FreshnessChecked 5 days agoFinal price, delivery and stock are confirmed at retailer checkout.
PRODUCT DETAILS
About this product
01
OverviewWhat matters most about this product
99% Pure | Multi Dose | Finished in the USA Cagrilintide is a powerful, long-acting analogue of the naturally secreted hormone amylin—co-released with insulin. Designed to probe appetite control , glycemic balance , and fat-metabolism in lab models, Cagrilintide slows gastric emptying, modulates satiety pathways, and drives body-fat reduction in rodent and primate studies. When paired with GLP-1 agonists like semaglutide or retatrutide, it delivers amplified metabolic effects.
Each 10 mg vial is HPLC-tested to ≥99% purity, endotoxin-screened (
